Esperion Therapeutics Inc (ESPR)

Currency in USD
3.180
-0.010(-0.31%)
Closed·
Showing Esperion historical data. For real-time data please try another search
Fair Value
Day's Range
3.1803.190
52 wk Range
1.1004.175
Key Statistics
Prev. Close
3.18
Open
3.18
Day's Range
3.18-3.19
52 wk Range
1.1-4.175
Volume
59.09M
Average Volume (3m)
15.61M
1-Year Change
169.4915%
Book Value / Share
-1.2
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ESPR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.190
Upside
+0.31%
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Esperion Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

0 Buy
6 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 3.190
(+0.31% Upside)

Esperion Therapeutics Inc Earnings Call Summary for Q4/2025

  • Q4 revenue surged 144% YoY to $168.45M, driven by $124.7M collaboration revenue including Otsuka milestone payment.
  • EPS of $0.22 missed forecast of $0.29 by 24%, though stock rose 7.24% in pre-market to $3.26 on revenue strength.
  • US net product revenue grew 38% to $43.7M; company ended year with strong cash position and reduced debt levels.
  • CEO Mayleben cited 2025 as best year on record; projects 2026 operating expenses of $225M-$255M including $15M stock compensation.
  • Growth strategy focuses on new product launches and international expansion through strategic partnerships to sustain momentum.
Last Updated: 03/10/2026, 08:56 PM
Read Full Transcript

Earnings

Latest Release
May 08, 2026
EPS / Forecast
-0.10 / -0.02
Revenue / Forecast
80.1M / 95.72M
EPS Revisions
Last 90 days

ESPR Income Statement

Compare ESPR to Peers and Sector

Metrics to compare
ESPR
Peers
Sector
Relationship
P/E Ratio
−110.4x0.0x−0.4x
PEG Ratio
−1.150.000.00
Price/Book
−2.7x0.0x2.6x
Price / LTM Sales
2.0x0.0x3.0x
Upside (Analyst Target)
−0.6%0.0%56.0%
Fair Value Upside
Unlock0.0%9.1%Unlock

People Also Watch

4.140
RXT
-5.69%
34.200
CUE
+2.21%
14.66
FLNC
-4.06%
16.060
MRAM
+0.19%
86.80
MXL
+0.86%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.